To compare the clinical efficacy among different acupuncture and moxibustion therapies on stable angina pectoris（SAP） of coronary heart disease by means of network Meta-analysis. The articles of randomized controlled trial（RCT） for SAP of coronary heart disease treated with acupuncture and moxibustion therapies were searched from PubMed

Web of Science

Cochrane Library

CNKI

Wanfang database and VIP database from May 1

2002 to May 1

2022. The quality of them was assessed with the risk of bias assessment tool of Cochrane 5.3

and the network Meta-analysis was undertaken with Stata 13.1 software. A total of 29 articles were included with the acupuncture and moxibustion therapies involved

e.g. acupuncture

acupoint application and moxibustion. In comparison with the simple routine western medication

the effective rate was better on SAP treated with the combined treatments

in which

acupoint application

moxibustion

acupuncture and intradermal needling were combined with routine western medication（P<0.05）. Of those combined treatments

the combination of the acupoint application with routine western medication had high probability

suggesting the optimal regimen（area under the curve [SUCRA]=0.711

P<0.05）. The effective rate of acupuncture combined with routine western medication for ECG improvement was better than that of routine western medication（P<0.05）

and such combined treatment was high in probability

underlying its optimal treatment（SUCRA=0.800

P<0.05）. Combined with routine western medication

acupuncture

acupoint application

moxibustion and intradermal needling all improve the clinical efficacy on SAP of coronary heart disease. But

with different outcomes considered

the optimal treatments may be different. It needs more multi-central and large-sample randomized controlled trials to validate these results.